Candida markers of urogenital biotopes diseases: reactivity to lectins of probiotics

Possibilities of using eukaryotic microorganisms (Candida spp.) of microbiocenoses of mucosal open cavities as potential biomarkers of pathological states of biotopes were investigated. To identify biotopes characterizing Candida strains we used new promising natural glycoconjugate recognition agents -lectins that imitate the effect of probiotics. The lectins were isolated from cultures of probiotic strains of lactobacillus and bifidus bacteria characterizing and supporting probiotic compartment of microbiocenosis of human mucosal open cavities as part of endogen sensory system "lectins of probiotic microorganisms - opportunistic eukaryotic yeast-like fungi". The study was carried out on examples of cases of dysbiotic disorders in the composition of microbiocenoses against the background of pathologies of the urogenital tract of patients with established diagnosis. Results demonstrate the early (before development of visible inflammatory reactions) presence of changed Candida cells in pathological biotopes of urogenital tract indicating states of diseases characterizing with increased differentiating affinities and sensitivities of Candida to a panel of probiotic lectins. Probiotic lectins are perspective in combinative prognostics and diagnostics of pathological states of functional biotopes of human mucosal open cavities as well as for prophylaxis and therapy of such states by compensation of deficit or absence of probiotic microflora to support healthy balance of mucosal immunity, instead of probiotics or in combinations with probiotics, antibiotics and other antimicrobial agents, therapeutics, and factors. The data also perspective in study of pathological biotope states possessing risk of conversion into tumor-like landscapes.

probiotic lectins, lactobacilli, bifidus bacteria, microbiocenoses, pathogens, Candida, urogenital tract, mucosal immunity, diseases, cerivicitis

1. Лахтин М.В., Козлов Л.В., Лахтин В.М., Алешкин В.А., Афанасьев С.С., Караулов А.В., Несвижский Ю.В., Байракова А.Л., Афанасьев М.С., Бичучер А.М., Панурина Р.Л., Рубальский Е.О. Защита потенциальных антител человека от протеолиза секретами клинических штаммов кандид в присутствии лектинов пробиотических бактерий человека // Астраханский медицинский журнал. - 2012. - Т. 7, № 1. - С. 63-68

2. Лахтин М.В., Лахтин В.М., Афанасьев С.С. Лектины пробиотиков против инфекционного процесса // Иммунопатология, аллергология, инфектология. -2017. - Прил. 1. - С. 52-53

3. Лахтин М.В., Лахтин В.М., Афанасьев С.С., Алешкин В.А. Лектины пробиотиков против болезней микробиоценозов в организме человека // Уральский научный вестник. - 2017. - Т. 2, № 9. - С. 35-45

4. Лахтин М.В., Лахтин В.М., Афанасьев С.С., Байракова А.Л., Алешкин В.А. Биопленкообразование в биотопном микробиоценозе человека: модель для прогностических расчетов межмикробных взаимосвязей // Бюл. ВСНЦ СО РАМН. - 2015. - № 3. - С. 56-62

5. Лахтин М.В., Лахтин В.М., Афанасьев С.С., Байракова А.Л., Караулов А.В., Афанасьев М.С. Мобильный синбиотопный микробиоценоз против патогенов // Бюл. ВСНЦ СО РАМН. - 2016. - № 3, Ч. 2. - С. 168-173

6. Микробиоценозы и здоровье человека / Под ред. В.А. Алешкина, С.С. Афанасьева, А.В. Караулова. -М.: Династия, 2015. - 548 с

7. Arendrup M.C. (2013). Candida and candidaemia. Susceptibility and epidemiology. Dan Med J, 60 (11), B4698.

8. Coelho L.C., Silva P.M., Lima V.L., Pontual E.V., Paiva P.M., Napoleâo T.H. (2017). Lectins, interconnecting proteins with biotechnological/pharmacological and therapeutic applications. Evid Based Complement Alternat Med, 1594074. doi: 10.1155/2017/1594074.

9. Domino S.E., Hurd E.A., Thomsson K.A., Karnak D.M., Holmén Larsson J.M., Thomsson E., Bäckström M., Hansson G.C. (2009). Cervical mucins carry alpha(1,2)fucosylat-ed glycans that partly protect from experimental vaginal candidiasis. Glycoconj J, 26 (9), 1125-1134. doi: 10.1007/s10719-009-9234-0.

10. Kong E.F., Tsui C., Kuchari'kova S., Andes D., Van Dijck P., Jabra-Rizk M.A. (2016). Commensal protection of Staphylococcus aureus against antimicrobials by Candida albicans biofilm matrix, 7 (5), pii: e01365-16. doi: 10.1128/mBio.01365-16.

11. Lakhtin M., Alyoshkin V., Lakhtin V., Afanasyev S., Pozhalostina L., Pospelova V. (2010). Probiotic lactobacillus and bifidobacterial lectins against Candida albicans and Staphylococcus aureus clinical strains: new class of pathogen biofilm destructors. Probiotics Antimicrob Proteins, 2 (3), 186-196. doi: 10.1007/s12602-010-9046-3.

12. Lakhtin M., Lakhtin V., Aleshkin A., Bajrakova A., Afanasiev S., Aleshkin V. (2012). Lectin systems imitating probiotics: potential for biotechnology and medical microbiology. Probiotics. New York, 417-432.

13. Lepargneur J.P. (2016). Lactobacillus crispatus as biomarker of the healthy vaginal tract. Ann Biol Clin (Paris), 74 (4), 421-427. doi: 10.1684/abc.2016.1169.

14. Nami Y., Abdullah N., Haghshenas B., Radiah D., Rosli R., Khosroushahi AY. (2014). Assessment of probiotic potential and anticancer activity of newly isolated vaginal bacterium Lactobacillus plantarum 5BL. Microbiol Immunol, 58 (9), 492-502. doi: 10.1111/13480421.12175.

15. Nami Y., Abdullah N., Haghshenas B., Radiah D., Rosli R., Khosroushahi A.Y. (2014). Probiotic potential and biotherapeutic effects of newly isolated vaginal Lactobacillus acidophilus 36YL strain on cancer cells. Anaerobe, 28, 29-36. doi: 10.1016/j.anaerobe.2014.04.012.

16. Niu X.X., Li T., Zhang X., Wang S.X., Liu Z.H. (2017). Lactobacillus crispatus modulates vaginal epithelial cell innate response to Candida albicans. Chin Med J (Engl.), 130 (3), 273-279. doi: 10.4103/0366-6999.198927.

17. Pericolini E., Gabrielli E., Amacker M., Kasper L., Roselletti E., Luciano E., Sabbatini S., Kaeser M., Moser C., Hube B., Vecchiarelli A., Cassone A. (2015). Secretory aspartyl proteinases cause vaginitis and can mediate vaginitis caused by Candida albicans in mice. MBio, 6 (3), e00724. doi: 10.1128/mBio.00724-15.

18. Zawrotniak M., Bochenska O., Karkowska-Kuleta J., Seweryn-Ozog K., Aoki W., Ueda M., Kozik A., Rapala-Kozik M. (2017). Aspartic proteases and major cell wall components in Candida albicans trigger the release of neutrophil extracellular traps. Front Cell Infect Microbiol, 7, 414. doi: 10.3389/fcimb.2017.00414.